Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (481-490 of 1,137) with videos related to

Pageof 114
Sort By:
The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.
Journal of Thrombosis and Thrombolysis|May 8, 2002
Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending arteryC Michael Gibson, Michael Chen, Brad G Angeja, et al.
The American Journal of Cardiology|August 15, 1995
Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency departmentC R Boisjolie, S W Sharkey, C P Cannon, et al.
Clinical Chemistry|December 18, 2008
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular deathBenjamin M Scirica, Christopher P Cannon, Marc S Sabatine, et al.
Cardiovascular Drugs and Therapy|September 17, 2003
Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromesCarlos V Serrano, José C Nicolau, Margareth Venturinelli, et al.
Heart (British Cardiac Society)|August 26, 2010
The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical careEric D Peterson, Matthew T Roe, Anita Y Chen, et al.
International Journal of Cardiology|February 7, 2018
Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®Nasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
The Journal of Bone and Joint Surgery. American Volume|August 3, 2007
Patient survival after surgery for osseous metastases from renal cell carcinomaPatrick P Lin, Attiqa N Mirza, Valerae O Lewis, et al.
Circulation|August 2, 2006
Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromesMichelle O'Donoghue, James A de Lemos, David A Morrow, et al.
The American Journal of Cardiology|July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)R C Becker, C P Cannon, E G Bovill, et al.
Pageof 114

Showing results (481-490 of 1,137) with videos related to

Sort By:
Pageof 114
The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.
Journal of Thrombosis and Thrombolysis|May 8, 2002
Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending arteryC Michael Gibson, Michael Chen, Brad G Angeja, et al.
The American Journal of Cardiology|August 15, 1995
Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency departmentC R Boisjolie, S W Sharkey, C P Cannon, et al.
Clinical Chemistry|December 18, 2008
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular deathBenjamin M Scirica, Christopher P Cannon, Marc S Sabatine, et al.
Cardiovascular Drugs and Therapy|September 17, 2003
Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromesCarlos V Serrano, José C Nicolau, Margareth Venturinelli, et al.
Heart (British Cardiac Society)|August 26, 2010
The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical careEric D Peterson, Matthew T Roe, Anita Y Chen, et al.
International Journal of Cardiology|February 7, 2018
Addition or removal of guideline directed medical therapy in ambulatory patients with heart failure with reduced ejection fraction relative to change in symptom severity: An analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®Nasrien E Ibrahim, Yang Song, Christopher P Cannon, et al.
The Journal of Bone and Joint Surgery. American Volume|August 3, 2007
Patient survival after surgery for osseous metastases from renal cell carcinomaPatrick P Lin, Attiqa N Mirza, Valerae O Lewis, et al.
Circulation|August 2, 2006
Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromesMichelle O'Donoghue, James A de Lemos, David A Morrow, et al.
The American Journal of Cardiology|July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)R C Becker, C P Cannon, E G Bovill, et al.
Pageof 114